Table 4.
PANSS positive | PANSS negative | RBANS | ||||
---|---|---|---|---|---|---|
HTZ | HMZ | HTZ | HMZ | HTZ | HMZ | |
Control | ||||||
AL-BS | NA | NA | NA | NA | NS | 0.94 (0.89–1.00) 0.03 |
AL-BL | NA | NA | NA | NA | NS | 1.07 (1.00–1.14) 0.02 |
BS | NA | NA | NA | NA | NS | NA |
AL | NA | NA | NA | NA | NS | NA |
AL-AL | NA | NA | NA | NA | NS | NA |
Schizophrenia | ||||||
AL-BS | NS | NS | NS | NS | NS | NS |
AL-BL | NS | NS | NS | NS | NS | NS |
BS | NS | 0.54 (0.33–0.88) 0.0001 |
NS | NS | NS | 0.82 0.76–0.90 0.0001 |
AL | NS | NS | 1.24 (1.09–1.40) 0.0001 |
8.62 (1.48–50.34) 0.0001 |
NS | 0.68 (0.55–0.83) 0.0001 |
AL-AL | 0.92 (0.85–1.00) 0.0001 |
NS | NS | NS | NS | NS |
OR – odds ratio; CI – confidence interval; p – p-value; HTZ – heterozygote; HMZ – homozygote; NS - not statistically significant at p<0.05; NA - not applicable (due to absence of homozygotes in the control group); PANSS positive refers to positive psychiatric symptoms; PANSS negative refers to negative psychiatric symptoms.
Comparison is HTZ and HMZ relative to absence of haplotype.